270 related articles for article (PubMed ID: 19110733)
1. Fluorescence imaging for the demarcation of basal cell carcinoma tumor borders.
Alkalay R; Alcalay J; Maly A; Ingber A; Fritsch C; Ruzicka T; Enk CD
J Drugs Dermatol; 2008 Nov; 7(11):1033-7. PubMed ID: 19110733
[TBL] [Abstract][Full Text] [Related]
2. Bispectral fluorescence imaging of aggressive basal cell carcinoma combined with histopathological mapping: a preliminary study indicating a possible adjunct to Mohs micrographic surgery.
Stenquist B; Ericson MB; Strandeberg C; Mölne L; Rosén A; Larkö O; Wennberg AM
Br J Dermatol; 2006 Feb; 154(2):305-9. PubMed ID: 16433801
[TBL] [Abstract][Full Text] [Related]
3. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
Hendrix JD; Parlette HL
Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
[TBL] [Abstract][Full Text] [Related]
4. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
5. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
[TBL] [Abstract][Full Text] [Related]
6. Rapid wound re-epithelialization and basal cell carcinoma clearance after Mohs micrographic surgery with postoperative photodynamic therapy.
Reddy KK; Hanke CW; Tierney EP
J Drugs Dermatol; 2010 Feb; 9(2):143-8. PubMed ID: 20214177
[TBL] [Abstract][Full Text] [Related]
7. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):452-7. PubMed ID: 16112352
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic diagnosis of tumor margins using methyl aminolevulinate before Mohs micrographic surgery.
Tierney E; Petersen J; Hanke CW
J Am Acad Dermatol; 2011 May; 64(5):911-8. PubMed ID: 21496702
[TBL] [Abstract][Full Text] [Related]
9. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):458-63. PubMed ID: 16112353
[TBL] [Abstract][Full Text] [Related]
10. A comparison of touch imprint cytology and Mohs frozen-section histology in the evaluation of Mohs micrographic surgical margins.
Florell SR; Layfield LJ; Gerwels JW
J Am Acad Dermatol; 2001 Apr; 44(4):660-4. PubMed ID: 11260543
[TBL] [Abstract][Full Text] [Related]
11. Mohs micrographic surgery at the Skin and Cancer Foundation Australia, 10 years later (1997 vs 2007).
Lim P; Paver R; Peñas PF
J Am Acad Dermatol; 2010 Nov; 63(5):832-5. PubMed ID: 20950738
[TBL] [Abstract][Full Text] [Related]
12. Nonmelanoma skin cancers of the ear: correlation between subanatomic location and post-Mohs micrographic surgery defect size.
Duffy KL; McKenna JK; Hadley ML; Tristani-Firouzi P
Dermatol Surg; 2009 Jan; 35(1):30-3. PubMed ID: 19018813
[TBL] [Abstract][Full Text] [Related]
13. Scalp tumors treated with Mohs micrographic surgery: clinical features and surgical outcome.
Leibovitch I; Huilgol SC; Richards S; Paver R; Selva D
Dermatol Surg; 2006 Nov; 32(11):1369-74. PubMed ID: 17083590
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia II. Perineural invasion.
Leibovitch I; Huilgol SC; Selva D; Hill D; Richards S; Paver R
J Am Acad Dermatol; 2005 Aug; 53(2):261-6. PubMed ID: 16021121
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Hill D; Richards S; Paver R
J Am Acad Dermatol; 2005 Aug; 53(2):253-60. PubMed ID: 16021120
[TBL] [Abstract][Full Text] [Related]
16. Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study.
van der Geer S; Martens J; van Roij J; Brand E; Ostertag JU; Verhaegh ME; Neumann HA; Krekels GA
Br J Dermatol; 2012 Jul; 167(1):110-5. PubMed ID: 22385074
[TBL] [Abstract][Full Text] [Related]
17. Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery.
Cherpelis BS; Turner L; Ladd S; Glass LF; Fenske NA
Dermatol Surg; 2009 Jul; 35(7):1050-6. PubMed ID: 19469800
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of photodynamic diagnosis in defining the lateral border between a tumor and a tumor-free area during Mohs micrographic surgery.
Lee CY; Kim KH; Kim YH
Dermatol Surg; 2010 Nov; 36(11):1704-10. PubMed ID: 20840493
[TBL] [Abstract][Full Text] [Related]
19. The Australian Mohs database, part I: periocular basal cell carcinoma experience over 7 years.
Malhotra R; Huilgol SC; Huynh NT; Selva D
Ophthalmology; 2004 Apr; 111(4):624-30. PubMed ID: 15051192
[TBL] [Abstract][Full Text] [Related]
20. Preoperative assessment of basal cell carcinoma using conventional fluorescence diagnosis.
Neus S; Gambichler T; Bechara FG; Wöhl S; Lehmann P
Arch Dermatol Res; 2009 Apr; 301(4):289-94. PubMed ID: 18979108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
